Efgartigimod Alfa Clinical Trials

2 actively recruiting trials across 1 location

▲ +1 trial since August 2026

Also known as: No other Intervention Names, Vyvgart Hytrulo

Pipeline

Phase 2: 2

Top Sponsors

Beijing Tongren Hospital1
Anastasia Vishnevetsky, MD, MPH1

Indications

Encephalitis Autoimmune1
Optic Neuritis1
Multiple Sclerosis1
Cancer1

Other1 trial

Efgartigimod in Anti-NMDA Receptor Encephalitis.

Phase 2

Boston, Massachusetts1 trial

Efgartigimod for the Treatment of Acute Optic Neuritis

Massachusetts Eye and Ear Infirmary

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.